Published Date: 29 Mar 2023
Surgeons can play an important role in reducing the risk of breast cancer by being aware of the probabilities and having an open discussion with patients about what to expect.
Read Full NewsIn a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to broader use.
Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?
The mistaken belief that stress can cause cancer leads many affected individuals to blame themselves for their cancer.
Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving hemoglobin at delivery and achieving better anemia resolution.
Platelet-rich plasma injections into the anterior vaginal wall enhance sexual function in premenopausal women.
The FDA said on Friday it has notified manufacturers of certain Parkinson's disease treatments to update their prescribing information with a...
In a nine-wave online survey of 418 adults over 18 months, researchers find fatigue levels do not fluctuate seasonally — only everyday activity fatigue falls as days lengthen.
1.
The main subject is associated with suicide in the United States.
2.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
3.
How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs
4.
Researchers Challenge USPSTF's Lung Cancer Screening Criteria
5.
LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization
1.
Unlocking the Potential of Elotuzumab: A Promising New Cancer Treatment
2.
From Bruises to Blood Clots: Everything You Need to Know about Hematoma
3.
The Digital Biopsy: How Artificial Intelligence is Redefining Cancer Pathology?
4.
Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial
5.
Understanding the HAS-BLED Score: What It Is and Why It Matters
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part X
5.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation